PortfoliosLab logoPortfoliosLab logo
ARKG vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ARKG vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARKG achieves a 17.09% return, which is significantly higher than XLVI's -0.67% return.


ARKG

1D
-0.24%
1M
10.92%
YTD
17.09%
6M
10.02%
1Y
53.35%
3Y*
0.67%
5Y*
-15.72%
10Y*
7.22%

XLVI

1D
0.67%
1M
2.30%
YTD
-0.67%
6M
0.76%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between ARKG and XLVI is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 31, 2025

0.42

ARKG vs. XLVI - Sectors Allocation Comparison


Sectors
ARKG
XLVI

Healthcare

99.2%

-

Financial Services

0.5%
100.6%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

ARKG
99.2%
XLVI

-

Financial Services

ARKG
0.5%
XLVI
100.6%

Basic Materials

ARKG

-

XLVI

-

Communication Services

ARKG

-

XLVI

-

Consumer Cyclical

ARKG

-

XLVI

-

Consumer Defensive

ARKG

-

XLVI

-

Energy

ARKG

-

XLVI

-

Industrials

ARKG

-

XLVI

-

Real Estate

ARKG

-

XLVI

-

Technology

ARKG

-

XLVI

-

Utilities

ARKG

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARKG vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG
ARKG Risk / Return Rank: 3535
Overall Rank
ARKG Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3737
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3232
Omega Ratio Rank
ARKG Calmar Ratio Rank: 3838
Calmar Ratio Rank
ARKG Martin Ratio Rank: 3131
Martin Ratio Rank

XLVI
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARKGXLVIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.22

Calmar ratioReturn relative to maximum drawdown

1.95

Martin ratioReturn relative to average drawdown

4.67

ARKG vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


ARKGXLVIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.31

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.35

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

0.13

1.33

-1.19

Drawdowns

ARKG vs. XLVI - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for ARKG and XLVI.


Loading charts...

Drawdown Indicators


ARKGXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

-8.14%

-75.45%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

Current Drawdown

Current decline from peak

-69.65%

-4.02%

-65.63%

Average Drawdown

Average peak-to-trough decline

-35.87%

-1.95%

-33.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.46%

Volatility

ARKG vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


ARKGXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.90%

Volatility (6M)

Calculated over the trailing 6-month period

28.77%

Volatility (1Y)

Calculated over the trailing 1-year period

41.12%

10.94%

+30.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.61%

10.94%

+34.67%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.12%

10.94%

+30.18%

ARKG vs. XLVI - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is higher than XLVI's 0.35% expense ratio.


Dividends

ARKG vs. XLVI - Dividend Comparison

ARKG has not paid dividends to shareholders, while XLVI's dividend yield for the trailing twelve months is around 11.53%.


PositionTTM202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%
XLVI
State Street Health Care Select Sector SPDR Premium Income ETF
11.53%5.73%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


ARKG and XLVI have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLVI is cheaper with a 0.35% expense ratio, compared with 0.75% for ARKG.

XLVI has the higher dividend yield at 11.53%, compared with 0.00% for ARKG.

ARKG is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: ARK and State Street. Their fees differ too: 0.75% for ARKG and 0.35% for XLVI.

Portfolio Optimizer

Find the right allocation for ARKG and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer